. The disease may be subdivided into embryonal (which accounts for about 60%), pleomorphic and alveolar types (Enzinger & Weiss, 1983) . Embryonal RMS is most commonly found in head and neck, genitourinary and retroperitoneal sites. Progress in the treatment of RMS has been achieved using combinations of surgery, radiotherapy and chemotherapy regimes (notably using vincristine, actinomycin D and cyclophosphamide, e.g. Quesada et al. (1986).
Summary A new human rhabdomyosarcoma cell line (HX170c) has been established from a paratesticular embryonal tumour in a 5-year-old male. The cells grew as an adherent monolayer with a doubling time of 32h and showed pleomorphic features. Intermediate filament analysis revealed the line to be mesenchymal in origin (reactivity to vimentin and desmin antibodies). The line was tumorigenic in nude mice, possessed elevated levels of creatine phosphokinase (mainly of the MM isoenzyme form) and had a near diploid mean chromosome number of 50. In vitro cell cloning determinations gave colony forming efficiencies of 0.01 % in soft agar and 24% in a monolayer anchorage-dependent assay. Radiosensitivity determinations using a monolayer clonogenic assay with feeder layer support showed the cells to be among the more radiosensitive human tumour cell types (surviving fraction at 2Gy of 0.26) that have been investigated. Furthermore, experiments utilising continuous low dose rate radiation at 3.2 cGy min-1, showed that, under these experimental conditions, the cells possessed only a very low capacity to recover from radiation-induced damage (dose reduction factor at 1% cell survival of 1.07 for 150 versus 3.2cGy min-'). As other human tumour cells of an embryonal cell origin (e.g. neuroblastoma and germ cell tumours of the testis) have also been shown to be radiosensitive it appears that sensitivity to radiation may be a common property of this group of tumours. Rhabdomyosarcoma (RMS) is the most common soft tissue sarcoma in childhood and represents 8% of all malignant disease in children under 15 years (Young & Miller, 1975) . The disease may be subdivided into embryonal (which accounts for about 60%), pleomorphic and alveolar types (Enzinger & Weiss, 1983) . Embryonal RMS is most commonly found in head and neck, genitourinary and retroperitoneal sites. Progress in the treatment of RMS has been achieved using combinations of surgery, radiotherapy and chemotherapy regimes (notably using vincristine, actinomycin D and cyclophosphamide, e.g. Quesada et al. (1986) .
In recent years a few in vitro RMS cell lines have been established from both alveolar (Nanni et al., 1986; Garvin et al., 1986) and embryonal (McAllister et al., 1969; Giard et al., 1973; Chapman et al., 1974; Clayton et al., 1986) types. The majority of studies to date with these lines have concentrated upon cell biological aspects of the disease, such as tumour specific markers (Nanni et al., 1986; Clayton et al., 1986) , growth factors (Iwata et al., 1985) and in vitro differentiation properties (Garvin et al., 1986) . Few studies have investigated chemotherapeutic aspects and none to our knowledge has investigated the radiobiological properties of this common childhood tumour where radiotherapy plays a role in its treatment.
Since it has become clear in recent years that the initial portion of the in vitro radiation cell survival curve for human tumour cells shows a positive correlation with clinical radioresponsiveness (Fertil & Malaise, 1981; Deacon et al., 1984; , it is of interest to determine radiosensitivity in various human tumour cell types. It has been shown that other childhood tumours derived from embryonic cell types, such as neuroblastoma (Deacon et al., 1985; , are particularly radiosensitive, possessing steep initial slopes to their survival curves. In addition, another embryonal cell type, a germ cell tumour of the testis cell line, has been shown to be among the more radiosensitive lines investigated in a series of studies involving human tumour cells (Kelland et al., 1987a,b; Steel et al., 1987) .
In this study we describe the establishment and characterisation of a new RMS cell line designated HX170c. In addition, by means of a clonogenic cell survival assay, radiosensitivity has been determined both at a high dose rate (150 cGy min 1) and at a continuous low dose rate of 3.2 cGy min 1 As has been shown previously (Mitchell et Correspondence: L.R. Kelland. Received 24 May 1988, and in revised form, 30 September 1988 30 September . al., 1979a Steel et al., 1986) , irradiation of cells of human origin, which generally have cell cycle times in excess of 24 h, at dose rates of around 3 cGy min-allows extensive recovery of radiation damage by repair processes without cell repopulation or cell cycle reassortment occurring, and enables a more precise indication of the initial slope of the cell survival curve to be obtained.
Materials and methods

Establishment of cell line
The cell line was established from a biopsy of a paratesticular embryonal rhabdomyosarcoma (diagnosed to be a rhabdomyosarcoma by positivity for desmin intermediate filaments) at the Royal Marsden Hospital in a 5-year-old caucasian male. The tumour had previously been treated with radio-and chemotherapy (vincristine, adriamycin and cyclophosphamide) over a 2-year period but had recurred locally at the time of biopsy removal in November 1986. The patient died 2 months after the biopsy was taken.
The biopsy was held in ice-cold Ham's F12 medium containing penicillin (105 units P1), streptomycin (100mg I1) and neomycin (10mg -1) for 2 h. The specimen was then finely chopped with crossed scalpels and rinsed in phosphate buffered saline (PBS). One-half of the material of 2mm2 size was implanted subcutaneously into five female (nu/nu) nude mice to establish xenografts. The remaining half was disaggregated overnight at 37C in Ham's F12 medium containing 15% fetal calf serum (Imperial Laboratories) and 1 mg ml-1 collagenase (Boehringer-Mannheim). After centrifugation (lOOg for 5min), single cells and cell aggregates were seeded into parallel 25 cm2 tissue culture flasks (Nunc products). (10,ugml-1) for the final 2 h. Cells were then disaggregated (0.02% EDTA/0.05% trypsin), centrifuged (lOOg, 5min) and swollen in hypotonic solution (0.075 M KCI) at 37°C for Omin. Cells were then fixed with ice-cold glacial acetic acid: methanol (1:3), dropped on to ice-cold slides, air dried and stained with 5% Giemsa for 10min. The mean chromosome number was determined by counting at least 30 metaphase spreads. Analysis was at passage 30.
Creatine phosphokinase (CPK) enzyme activity Both total CPK activity and isoenzyme separation were determined using kits (Sigma Chemical Co.). Cells were grown to confluency, washed in PBS and then harvested.
After centrifugation (lOOg, 5min), the resulting cell pellet was resuspended in 0.5ml PBS and cells were disrupted by sonication. Total CPK activity determinations utilised phosphocreatine and ADP as substrates in a colorimetric analysis. For isoenzyme separation into BB, MB and MM forms the supernatant was placed on 0.8% agarose gel and, after electrophoresis, quantitation was achieved using tetranitro-blue tetrazolium reduction colorimetry.
Colony forming efficiency (CFE) CFE was determined both in monolayer on plastic and in soft agar. For both assays, single cell suspensions were obtained by disaggregation using 0.02% EDTA in 0.05% trypsin and filtration through a 20 gtm polyester mesh.
Assays were then performed as previously described for other human tumour cell types (Kelland et al., 1987a; for monolayer assay; Courtenay & Mills, 1978; Kelland & Steel, 1986 for soft agar assay). Briefly, cells (250 to 1 x 104) were seeded and incubated in 'growth medium' as above except that a lethally irradiated feeder layer of 3T3 cells was included. For the monolayer assay 2 x 105 feeder cells were added per 60 mm plate, whereas in the soft agar assay 1 x 104 cells per tube were added. As with a number of other human tumour cell types studied (Kelland et al., 1987a (Kelland et al., ,b, 1988 Irradiation procedure Single cells were plated out according to the monolayer clonogenic assay described above and radiation survival using 60Co y-rays determined as previously described for other human tumour cell types (Kelland et al., 1987a (Kelland et al., , b, 1988 . Briefly, cells were gassed for 30min with a 90% N2, 5% CO2, 5% 02 mixture, sealed into boxes, incubated at 37°C for 90min and then irradiated. High (150cGymin-1) and low (3.2cGymin-1) irradiations were performed using either a 2,000Ci or a 10OCi source, both with identical geometry. Irradiations were carried out with cells at 37°C. Cells were then incubated for 14 days and colonies containing greater than 50 cells counted.
Statistical analysis
Radiation survival points represent the mean + standard error of at least three experiments. Single survival curves were fitted using the incomplete repair model for survival under continuous irradiation (Thames, 1985) .
Results
The cell line HX170c has now been growing in tissue culture for 15 months and has been passaged at least 80 times. Figure 1 Figure 2 (a is original biopsy; b is xenograft from original biopsy; and c is xenograft from cell line). Figure 2a shows (determined using the monolayer cloning assay) for HX1 70c at both high and low radiation dose-rate. At the high doserate of 150 cGy min -1 the curve is almost exponential in shape, possessing a negligible initial shoulder at low doses. Irradiation at the low dose rate of 3.2 cGy min-1, which allows repair processes to operate during irradiation, results in a very small shift in the curve to the right. Cell survival parameters derived from these curves are shown in Table I .
Discussion
To date, relatively few cell lines have been established from this important tumour of childhood (McAllister et al., 1969; Giard et al., 1973; Clayton et al., 1986) , possibly reflecting a difficulty in establishing these cell types in vitro. In addition, some alveolar RMS lines have been established (Nanni et al., 1986; Garvin et al., 1986) . The biological properties of the HX170c cell line described here are consistent with it being derived from a human embryonal rhabdomyosarcoma and it shows a number of similar features to the existing cell lines.
The cell line was confirmed as human in origin by reactivity against the GCTM-1 monoclonal antibody and to be tumorigenic in nude mice. Where tumorigenicity has been investigated in existing lines (Giard et al., 1973; Nanni et al., 1986; Garvin et al., 1986; Clayton et al., 1986) tumours have also arisen after about the same time of 6 weeks. Indeed the lines described by Hazelton et al. (1987) were established from xenograft lines. Cytogenetic analysis showed a near diploid mean chromosome number of 50, a number close to that observed in some other lines (Giard et al., 1973; Chapman et al., 1974; McAllister et al., 1969; Garvin et al., 1986) . However, occasionally much higher chromosome numbers of around 85 per cell have been observed (Clayton et al., 1986; Nanni et al., 1986) .
The development of intermediate filament analysis has aided the classification of human tumours (Osborn & Weber, 1982) . The diagnosis of RMS has been helped by the finding that, in biopsy sections, RMS and leiomyosarcoma are reactive with desmin-type intermediate filaments (Osborn et al., 1984; Altmannsberger et al., 1985) . Although cell lines derived from RMS have also been shown to react with antidesmin monoclonal antibodies, the proportion of positivestaining cells has varied from around 80-90% in the human RD line (Debus et al., 1983) and 80% in the RMZ alveolar RMS line (Nanni et al., 1986) to around 20-30% in the JR1 embryonal RMS line (Clayton et al., 1986) . We observed desmin expression in only around 5% of cells when seeded at low density, in around 20% of the population (particularly in elongated multinucleated cells) when cells were near confluent and in about 60% of tumour areas in xenograft sections derived from the cells (a similar proportion to the original biopsy). These findings emphasise the importance of cell growth conditions for desmin expression.
As with other cell lines (Clayton et al., 1986; Hazelton et al., 1987) , the HX170c cells were positive for vimentin expression, thus confirming the mesenchymal origin of the cells. In addition, in agreement with previous findings, the cells were negative for cytokeratin expression. Myoglobin has also been proposed as a marker for RMS (Corson & Pinkus, 1981) , although it is now apparent that not all are identified (Altmannsberger et al., 1985) . We did not detect myoglobin in either the cells or resulting xenograft lines. Other RMS cell lines have also been shown to be negative for myoglobin expression (McAllister et al., 1969; Clayton et al., 1986) .
Creatine phosphokinase (CPK) isoenzyme determinations are also useful in characterizing RMS. We have shown HX170c to possess elevated CPK levels largely of the 'adult' MM homodimer. Where isoenzyme levels have been measured in other RMS lines the MM form is usually dominant (Hazelton et al., 1987) . As the MM form is dominant in all stages of skeletal muscle development our findings are not surprising. However, Garvin et al. (1986) have reported the BB form to be dominant in a RMS cell line.
Colony forming efficiency determinations revealed large differences in cloning ability in soft agar (0.01%) compared to an anchorage-dependent monolayer assay (24%). Interestingly, in the only other investigation we know of where cell cloning has been attempted in a human RMS cell line (Giard et al., 1973 for the A-673 line) a similar result was obtained (cloning efficiencies of 2.4% in agar and 70% in monolayer). In addition, we have seen this difference in cloning ability between soft agar and monolayer assays for other human tumour cell types, particularly lines of epithelial origin (e.g. carcinoma of the cervix; Kelland et al., 1987a) .
As far as we are aware this is the first time a human rhabdomyosarcoma cell line has been the subject of a radiobiological analysis. On comparison with over 20 other human tumour cell types that we have looked at in our laboratory (Steel et al., 1987; for reviews) the HX170c RMS cell line with a Do of 1.27Gy, oc of 0.64Gy and a SF2 value of 0.26 is among the most radiosensitive. The SF2 value for human tumour cells has been shown to be a good discriminator between clinically radioresponsive and unresponsive tumour types (Deacon et al., 1984) . According to this classification of radiosensitivity HX170c may be assigned to Group B, the group containing medulloblastoma, small cell lung carcinoma and teratoma. As well as being quite radiosensitive, survival measured at the low dose rate of 3.2 cGy min-1 indicates that the cells, under these experimental conditions, appear to possess only a small capacity to recover from radiation damage (Figure 3 , DRF of only 1.07 from Table I ). This DRF value is one of the lowest we have observed among the human tumour cell lines studied (where we have found DRF values ranging from 1.0 to 2.1 (Steel et al. 1987) .
In addition to the observed correlation between SF2 and clinical radioresponsiveness (Deacon et al., 1984; , it has been proposed that the degree of potentially lethal damage repair (PLDR) (that observed by delayed plating experiments) observed in vitro in human tumour cells may also correlate with clinical responsiveness (Weichselbaum & Beckett, 1987; Weichselbaum et al., 1982) . Therefore it would appear that PLDR experiments may represent an alternative strategy for examining radiosensitivity and correlations with radioresponsiveness. However, in view of the difficulty in obtaining true plateau phase cells with human tumour cells which are not contact inhibited as confluent monolayers, combined with recent evidence that has not shown any such correlation (Marchese et al., 1987) , we believe that the SF2 and low dose rate determinations described above provide the ideal means of assessing radiosensitivity in vitro.
Obviously from data representing only one cell line it is not possible to predict whether the radiosensitive properties of HX170c found here are a general characteristic of human RMS. However, of interest is the finding that other human cell lines of an embryonal cell origin are also radiosensitive. For example, neuroblastoma cell lines have been shown to be even more radiosensitive (Deacon et al., 1985; . In addition we have shown a germ cell tumour of the testis cell line to be of about the same radiosensitivity (Kelland et al., 1987b) . At present it is not clear why tumour cells of an embryonal cell origin generally appear to be intrinsically more radiosensitive than the majority of human tumour cell types. It is possible that these cells are deficient in some DNA-repair pathway or that they incur more initial damage per radiation dose due to differences in chromatin organisation. As yet no such differences have been observed. Further studies on additional cell lines of embryonal origin (which have thus far proved difficult to establish) are necessary. These questions are important to answer in order to elucidate what makes a cell sensitive to radiation and whether such determinants may be manipulated in more radioresistant tumours. The HX170c cell line described in this study may prove useful for investigating some of these questions.
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